Overview of the epidemic characteristics of Mycoplasma pneumoniae infection around COVID pandemic
iLABMED · 2023
DOI: 10.1002/ila2.27 ↗Kurz gefasst
Fachartikel in der Zeitschrift iLABMED, 2023. Verfasst von Hongmei Sun und 1 weiteren Autor:innen. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Mycoplasma pneumoniae ( M. pneumoniae ) is a cell wall‐less respiratory pathogen causing community‐acquired pneumonia and extrapulmonary manifestations. It is transmitted through close contact and shows periodic regional outbreaks. The coronavirus disease (COVID‐19) pandemic interfered with the global spread of M. pneumoniae . A large‐scale post‐COVID outbreak is currently ongoing in China. To help physicians better understand and manage this epidemic, we provide this review summarizing current knowledge on the pathogenesis, epidemic characteristics, macrolide resistance, diagnostic methods, and clinical treatment strategies for this pathogen.
Zitieren
APA
Sun, H., & Xiao, L. (2023). Overview of the epidemic characteristics of Mycoplasma pneumoniae infection around COVID pandemic. iLABMED. https://doi.org/10.1002/ila2.27
Vancouver
Sun H, Xiao L. Overview of the epidemic characteristics of Mycoplasma pneumoniae infection around COVID pandemic. iLABMED. 2023. doi:10.1002/ila2.27
BibTeX
@article{Sun2023,
author = {Sun, Hongmei and Xiao, Li},
title = {Overview of the epidemic characteristics of Mycoplasma pneumoniae infection around COVID pandemic},
journal = {iLABMED},
year = {2023},
doi = {10.1002/ila2.27}
}
EUVIMED